CADAMURO MASSIMILIANO

Di Pasqua, L., Cagna, M., Palladini, G., Croce, A., Cadamuro, M., Fabris, L., et al. (2024). FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH. LIVER INTERNATIONAL, 44(1 (January 2024)), 214-227 [10.1111/liv.15767]. Dettaglio

Romanzi, A., Milosa, F., Marcelli, G., Critelli, R., Lasagni, S., Gigante, I., et al. (2024). Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids. BIOMEDICINES, 12(1) [10.3390/biomedicines12010087]. Dettaglio

Cadamuro, M., Sarcognato, S., Camerotto, R., Girardi, N., Lasagni, A., Zanus, G., et al. (2023). Intrahepatic cholangiocarcinoma developing in patients with metabolic syndrome is characterized by Osteopontin overexpression in the tumor stroma. In Abstract Book of EASL Congress 2023 21-24 June 2023 • Vienna, Austria (pp.564-565). Elsevier [10.1016/S0168-8278(23)01358-2]. Dettaglio

Fabris, L., Campello, E., Cadamuro, M., Simioni, P. (2023). The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit. BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE [10.1016/j.bbadis.2023.166763]. Dettaglio

Rainone, P., Valtorta, S., Villa, C., Todde, S., Cadamuro, M., Bertoli, G., et al. (2023). Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(18) [10.3390/ijms241814124]. Dettaglio